• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

Exploring the Potential of 9-Methyl-9H-Purine-6-Carboxylic Acid: A Comprehensive Overview

The compound with CAS No. 1095822-37-9, known as 9-methyl-9H-purine-6-carboxylic acid, has garnered significant attention in the scientific community due to its unique chemical structure and potential applications in various fields. This compound belongs to the purine family, which is a fundamental class of heterocyclic organic compounds playing crucial roles in biology, particularly in nucleic acids and energy transfer molecules like ATP and GTP.

Purine derivatives have been extensively studied for their diverse biological activities, including anti-inflammatory, antiviral, and anticancer properties. The addition of a methyl group at the 9-position and a carboxylic acid group at the 6-position in 9-methyl-9H-purine-6-carboxylic acid introduces unique functional groups that may enhance its bioavailability and interaction with biological systems. Recent studies have highlighted its potential as a lead compound for drug development, particularly in the context of targeting specific cellular pathways.

The synthesis of 9-methyl-9H-purine-6-carboxylic acid involves a multi-step process that typically begins with the preparation of purine derivatives followed by functionalization to introduce the methyl and carboxylic acid groups. Researchers have explored various synthetic routes, including microwave-assisted synthesis and enzymatic catalysis, to optimize the production process and improve yield. These advancements have not only made the compound more accessible for research purposes but also opened avenues for its commercial application.

From a pharmacological perspective, 9-methyl-9H-purine-6-carboxylic acid has shown promising results in preclinical studies. For instance, it has demonstrated selective inhibition of certain kinases involved in cancer progression, suggesting its potential as an anticancer agent. Additionally, its ability to modulate immune responses has led to investigations into its use in autoimmune diseases and inflammatory conditions.

Recent breakthroughs in computational chemistry have further enhanced our understanding of the molecular interactions of 9-methyl-9H-purine-6-carboxylic acid. Molecular docking studies have revealed its binding affinity to key proteins associated with neurodegenerative diseases such as Alzheimer's and Parkinson's, indicating its potential role in neuroprotective therapies.

In terms of therapeutic applications, purine-based compounds are increasingly being explored for their role in targeting metabolic pathways. The carboxylic acid group in 9-methyl-9H-purine-6-carboxylic acid may facilitate its uptake into cells, enhancing its bioavailability and effectiveness as a drug candidate.

Moreover, the compound's structural versatility allows for further modification to tailor its properties for specific therapeutic applications. For example, researchers are investigating the effects of substituting different groups at the methyl or carboxylic acid positions to enhance selectivity or reduce potential side effects.

In conclusion, 9-methyl-9H-purine-6-carboxylic acid represents a promising compound with diverse applications across multiple fields. Its unique chemical structure, coupled with advancements in synthetic methods and pharmacological research, positions it as a valuable tool in drug discovery and development.

• 1095822-39-1(7-methyl-7H-Purine-6-carboxylic acid)
• 1368352-84-4(1-methyl-1H,4H-pyrrolo2,3-dimidazole-5-carboxylic acid)
• 98557-68-7(2-Chloro-9-(2-chloroethyl)-9H-purine-6-carboxylic acid)
• 1095823-05-4(Ethyl 8,9-dimethyl-9H-purine-6-carboxylate)
• 882213-41-4(9H-Purine-6-carboxylicacid, 2-amino-)
• 1095823-07-6(8,9-dimethyl-9H-Purine-6-carboxylic acid)
• 2365-43-7(9H-purine-6-carboxylic acid)
• 1557814-92-2(3-methyl-3H-imidazo4,5-bpyridine-5-carboxylic acid)
• 1078168-26-9(1-methyl-1H-Imidazo[4,5-c]pyridine-4-carboxylic acid)
• 2803476-85-7(Methyl 9-methyl-9H-purine-6-carboxylate)